rs1131692331
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM4_SupportingPP5_Moderate
The NM_006345.4(SLC30A9):c.1049_1051delCAG(p.Ala350del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_006345.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC30A9 | NM_006345.4 | c.1049_1051delCAG | p.Ala350del | disruptive_inframe_deletion | Exon 12 of 18 | ENST00000264451.12 | NP_006336.3 | |
SLC30A9 | XM_047449525.1 | c.1049_1051delCAG | p.Ala350del | disruptive_inframe_deletion | Exon 12 of 13 | XP_047305481.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC30A9 | ENST00000264451.12 | c.1049_1051delCAG | p.Ala350del | disruptive_inframe_deletion | Exon 12 of 18 | 1 | NM_006345.4 | ENSP00000264451.6 | ||
SLC30A9 | ENST00000509683.5 | n.105_107delCAG | non_coding_transcript_exon_variant | Exon 2 of 6 | 3 | |||||
SLC30A9 | ENST00000513699.5 | n.*806_*808delCAG | non_coding_transcript_exon_variant | Exon 13 of 19 | 2 | ENSP00000423529.1 | ||||
SLC30A9 | ENST00000513699.5 | n.*806_*808delCAG | 3_prime_UTR_variant | Exon 13 of 19 | 2 | ENSP00000423529.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome Pathogenic:2
The in-frame deletion NM_006345.4(SLC30A9):c.1049_1051delCAG (p.Ala350del) has been reported previously in 6 individuals from a Bedouin kindred affected with Birk-Landau-Perez syndrome (Perez et al., 2017). This variant is not present in gnomAD database (Karczewski et al., 2020) and Middle Eastern specific databases (Koshy et al., 2017). The removed amino acid is highly conserved and is located at the predicted cation-efflux domain of the mature SLC30A9 protein. In vitro functional studies in human neuroblastoma cells showed a significant decrease in cytosolic free Zn2+ levels in cells expressing the mutant compared to the wild type. (Perez et al., 2017).Further, in CRISPR-Cas9 knockout (SLC30A9 -/-) cell lines, functional complementation of the p.Ala350Del variant failed to restore the functional defect caused by genetic ablation of SLC30A9, indicating that the p.Ala350Del variant is a loss-of-function allele (Deng et al., 2021). Aggregating all the available evidence (PM2, PM1, PS3, PP1_strong), this variant has been classified as Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at